Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose.

Detalles Bibliográficos
Autores principales: Eliakim-Raz, Noa, Stemmer, Amos, Ghantous, Nassem, Ness, Asaf, Awwad, Muhammad, Leibovici-Weisman, Yaara, Stemmer, Salomon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305380/
https://www.ncbi.nlm.nih.gov/pubmed/35862048
http://dx.doi.org/10.1001/jamanetworkopen.2022.23090
_version_ 1784752311027892224
author Eliakim-Raz, Noa
Stemmer, Amos
Ghantous, Nassem
Ness, Asaf
Awwad, Muhammad
Leibovici-Weisman, Yaara
Stemmer, Salomon M.
author_facet Eliakim-Raz, Noa
Stemmer, Amos
Ghantous, Nassem
Ness, Asaf
Awwad, Muhammad
Leibovici-Weisman, Yaara
Stemmer, Salomon M.
author_sort Eliakim-Raz, Noa
collection PubMed
description This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose.
format Online
Article
Text
id pubmed-9305380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-93053802022-08-11 Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults Eliakim-Raz, Noa Stemmer, Amos Ghantous, Nassem Ness, Asaf Awwad, Muhammad Leibovici-Weisman, Yaara Stemmer, Salomon M. JAMA Netw Open Research Letter This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose. American Medical Association 2022-07-21 /pmc/articles/PMC9305380/ /pubmed/35862048 http://dx.doi.org/10.1001/jamanetworkopen.2022.23090 Text en Copyright 2022 Eliakim-Raz N et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Eliakim-Raz, Noa
Stemmer, Amos
Ghantous, Nassem
Ness, Asaf
Awwad, Muhammad
Leibovici-Weisman, Yaara
Stemmer, Salomon M.
Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title_full Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title_fullStr Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title_full_unstemmed Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title_short Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
title_sort antibody titers after a third and fourth sars-cov-2 bnt162b2 vaccine dose in older adults
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305380/
https://www.ncbi.nlm.nih.gov/pubmed/35862048
http://dx.doi.org/10.1001/jamanetworkopen.2022.23090
work_keys_str_mv AT eliakimraznoa antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT stemmeramos antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT ghantousnassem antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT nessasaf antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT awwadmuhammad antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT leiboviciweismanyaara antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults
AT stemmersalomonm antibodytitersafterathirdandfourthsarscov2bnt162b2vaccinedoseinolderadults

Ejemplares similares